Ulcerative Colitis? Time for a change!!!
The pharmaceutical company Celgene is conducting a new clinical trial for people with ulcerative colitis. The True North Study is determining the safety and effectiveness of an investigational oral drug for adults 18–75 years of age with ulcerative colitis (UC).
WHO MAY QUALIFY?
The study is open to those who meet the following criteria:
· Are 18–75 years of age
· Have a diagnosis of moderate to severe ulcerative colitis